|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
Statistics, 2017. CA Cancer J Clin. 67:7–30. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Nie Y, Wu K, Yu J, Liang Q, Cai X, Shang
Y, Zhou J, Pan K, Sun L, Fang J, et al: A global burden of gastric
cancer: The major impact of China. Expert Rev Gastroenterol
Hepatol. 11:651–661. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ørom UA, Derrien T, Beringer M, Gumireddy
K, Gardini A, Bussotti G, Lai F, Zytnicki M, Notredame C, Huang Q,
et al: Long noncoding RNAs with enhancer-like function in human
cells. Cell. 143:46–58. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Quinn JJ and Chang HY: Unique features of
long non-coding RNA biogenesis and function. Nat Rev Genet.
17:47–62. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wilusz JE, Sunwoo H and Spector DL: Long
noncoding RNAs: Functional surprises from the RNA world. Genes Dev.
23:1494–1504. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bartonicek N, Maag JL and Dinger ME: Long
noncoding RNAs in cancer: Mechanisms of action and technological
advancements. Mol Cancer. 15:432016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Nam JW, Choi SW and You BH: Incredible
RNA: Dual functions of coding and noncoding. Mol Cells. 39:367–374.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Huang JZ, Chen M, Chen, Gao XC, Zhu S,
Huang H, Hu M, Zhu H and Yan GR: A peptide encoded by a putative
lncRNA HOXB-AS3 suppresses colon cancer growth. Mol Cell.
68(171–184): e62017.
|
|
9
|
Matsumoto A, Pasut A, Matsumoto M,
Yamashita R, Fung J, Monteleone E, Saghatelian A, Nakayama KI,
Clohessy JG and Pandolfi PP: mTORC1 and muscle regeneration are
regulated by the LINC00961-encoded SPAR polypeptide. Nature.
541:228–232. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Roberts TC, Morris KV and Weinberg MS:
Perspectives on the mechanism of transcriptional regulation by long
non-coding RNAs. Epigenetics. 9:13–20. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Gibb EA, Brown CJ and Lam WL: The
functional role of long non-coding RNA in human carcinomas. Mol
Cancer. 10:382011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhang JF, Sun ZS, Zhang QF, Ding WF, Wu XH
and Mao ZB: Expression of long noncoding RNA STCAT3 in gastric
cancer tissues and its effect on malignant phenotype of gastric
cancer cells. Zhonghua Yi Xue Za Zhi. 96:3735–3740. 2016.(In
Chinese). PubMed/NCBI
|
|
13
|
Zhang JF, Qu LS, Qian XF, Xia BL, Mao ZB
and Chen WC: Nuclear transcription factor CDX2 inhibits gastric
cancer-cell growth and reverses epithelial-to-mesenchymal
transition in vitro and in vivo. Mol Med Rep.
12:5231–5238. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Guan C, Zhang J, Zhang J, Shi H and Ni R:
Enhanced expression of early mitotic inhibitor-1 predicts a poor
prognosis in esophageal squamous cell carcinoma patients. Oncol
Lett. 12:114–120. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Stewart GD, Skipworth RJ, Pennington CJ,
Lowrie AG, Deans DA, Edwards DR, Habib FK, Riddick AC, Fearon KC
and Ross JA: Variation in dermcidin expression in a range of
primary human tumours and in hypoxic/oxidatively stressed human
cell lines. Br J Cancer. 99:126–132. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chang WC, Huang MS, Yang CJ, Wang WY, Lai
TC, Hsiao M and Chen CH: Dermcidin identification from exhaled air
for lung cancer diagnosis. Eur Respir J. 35:1182–1185. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ortega-Martínez I, Gardeazabal J,
Erramuzpe A, Sanchez-Diez A, Cortés J, García-Vázquez MD,
Pérez-Yarza G, Izu R, Luís Díaz-Ramón J, de la Fuente IM, et al:
Vitronectin and dermcidin serum levels predict the metastatic
progression of AJCC I–II early-stage melanoma. Int J Cancer.
139:1598–1607. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yun J, Mullarky E, Lu C, Bosch KN,
Kavalier A, Rivera K, Roper J, Chio II, Giannopoulou EG, Rago C, et
al: Vitamin C selectively kills KRAS and BRAF mutant
colorectal cancer cells by targeting GAPDH. Science. 350:1391–1396.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang CY, Chen CL, Tseng YL, Fang YT, Lin
YS, Su WC, Chen CC, Chang KC, Wang YC and Lin CF: Annexin A2
silencing induces G2 arrest of non-small cell lung
cancer cells through p53-dependent and -independent mechanisms. J
Biol Chem. 287:32512–32524. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Feng X, Liu H, Zhang Z, Gu Y, Qiu H and He
Z: Annexin A2 contributes to cisplatin resistance by activation of
JNK-p53 pathway in non-small cell lung cancer cells. J Exp Clin
Cancer Res. 36:1232017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Rogers MS, Foley MA, Crotty TB, Hartmann
LC, Ingle JN, Roche PC and Strehler EE: Loss of immunoreactivity
for human calmodulin-like protein is an early event in breast
cancer development. Neoplasia. 1:220–225. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Brooks MD, Bennett RD, Strehler EE, Sebo
TJ, Eckert SE and Carr AB: Human calmodulin-like protein (CLP)
expression in oral squamous mucosa and in malignant transformation.
J Prosthodont. 18:11–16. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yang L, Cui M, Zhang L and Song L: FOXM1
facilitates gastric cancer cell migration and invasion by inducing
Cathepsin D. Oncotarget. 8:68180–68190. 2017.PubMed/NCBI
|
|
24
|
Zhu J, Wu G, Li Q, Gong H, Song J, Cao L,
Wu S, Song L and Jiang L: Overexpression of suprabasin is
associated with proliferation and tumorigenicity of esophageal
squamous cell carcinoma. Sci Rep. 6:215492016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Miller KD, Siegel RL, Lin CC, Mariotto AB,
Kramer JL, Rowland JH, Stein KD, Alteri R and Jemal A: Cancer
treatment and survivorship statistics, 2016. CA Cancer J Clin.
66:271–289. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Huarte M: The emerging role of lncRNAs in
cancer. Nat Med. 21:1253–1261. 2015. View
Article : Google Scholar : PubMed/NCBI
|
|
27
|
Schmitt AM and Chang HY: Long Noncoding
RNAs in cancer pathways. Cancer Cell. 29:452–463. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Gupta RA, Shah N, Wang KC, Kim J, Horlings
HM, Wong DJ, Tsai MC, Hung T, Argani P, Rinn JL, et al: Long
non-coding RNA HOTAIR reprograms chromatin state to promote cancer
metastasis. Nature. 464:1071–1076. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Arab K, Park YJ, Lindroth AM, Schäfer A,
Oakes C, Weichenhan D, Lukanova A, Lundin E, Risch A, Meister M, et
al: Long noncoding RNA TARID directs demethylation and
activation of the tumor suppressor TCF21 via GADD45A. Mol
Cell. 55:604–614. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Gooding AJ, Zhang B, Jahanbani FK, Gilmore
HL, Chang JC, Valadkhan S and Schiemann WP: The lncRNA BORG drives
breast cancer metastasis and disease recurrence. Sci Rep.
7:126982017. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Lu X, Huang C, He X, Liu X, Ji J, Zhang E,
Wang W and Guo R: A novel long non-coding RNA, SOX21-AS1, indicates
a poor prognosis and promotes lung adenocarcinoma proliferation.
Cell Physiol Biochem. 42:1857–1869. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Yu X and Li Z: Long non-coding RNA HOTAIR:
A novel oncogene (Review). Mol Med Rep. 12:5611–5618. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Chen WM, Chen WD, Jiang XM, Jia XF, Wang
HM, Zhang QJ, Shu YQ and Zhao HB: HOX transcript antisense
intergenic RNA represses E-cadherin expression by binding to EZH2
in gastric cancer. World J Gastroenterol. 23:6100–6110. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Yang F, Xue X, Zheng L, Bi J, Zhou Y, Zhi
K, Gu Y and Fang G: Long non-coding RNA GHET1 promotes gastric
carcinoma cell proliferation by increasing c-Myc mRNA stability.
FEBS J. 281:802–813. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zhang X, Bo P, Liu L, Zhang X and Li J:
Overexpression of long non-coding RNA GHET1 promotes the
development of multidrug resistance in gastric cancer cells. Biomed
Pharmacother. 92:580–585. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Wang ZQ, He CY, Hu L, Shi HP, Li JF, Gu
QL, Su LP, Liu BY, Li C and Zhu Z: Long noncoding RNA UCA1 promotes
tumour metastasis by inducing GRK2 degradation in gastric cancer.
Cancer Lett. 408:10–21. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
López-Sánchez LM, Jurado-Gámez B,
Feu-Collado N, Valverde A, Cañas A, Fernández-Rueda JL, Aranda E
and Rodríguez-Ariza A: Exhaled breath condensate biomarkers for the
early diagnosis of lung cancer using proteomics. Am J Physiol Lung
Cell Mol Physiol. 313:L664–L676. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Trzoss L, Fukuda T, Costa-Lotufo LV,
Jimenez P, La Clair JJ and Fenical W: Seriniquinone, a selective
anticancer agent, induces cell death by autophagocytosis, targeting
the cancer-protective protein dermcidin. Proc Natl Acad Sci USA.
111:14687–14692. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Moreira DF, Strauss BE, Vannier E and
Belizário JE: Genes up- and down-regulated by dermcidin in breast
cancer: A microarray analysis. Genet Mol Res. 7:925–932. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Brauer HA, D'Arcy M, Libby TE, Thompson
HJ, Yasui YY, Hamajima N, Li CI, Troester MA and Lampe PD:
Dermcidin expression is associated with disease progression and
survival among breast cancer patients. Breast Cancer Res Treat.
144:299–306. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Bancovik J, Moreira DF, Carrasco D, Yao J,
Porter D, Moura R, Camargo A, Fontes-Oliveira CC, Malpartida MG,
Carambula S, et al: Dermcidin exerts its oncogenic effects in
breast cancer via modulation of ERBB signaling. BMC Cancer.
15:702015. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Lowrie AG, Dickinson P, Wheelhouse N,
Stewart GD, Ross AJ, Forster T and Ross JA: Proteolysis-inducing
factor core peptide mediates dermcidin-induced proliferation of
hepatic cells through multiple signalling networks. Int J Oncol.
39:709–718. 2011.PubMed/NCBI
|
|
43
|
Shen SL, Qiu FH, Dayarathna TK, Wu J,
Kuang M, Li SS, Peng BG and Nie J: Identification of Dermcidin as a
novel binding protein of Nck1 and characterization of its role in
promoting cell migration. Biochim Biophys Acta. 1812:703–710. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Stewart GD, Lowrie AG, Riddick AC, Fearon
KC, Habib FK and Ross JA: Dermcidin expression confers a survival
advantage in prostate cancer cells subjected to oxidative stress or
hypoxia. Prostate. 67:1308–1317. 2007. View Article : Google Scholar : PubMed/NCBI
|
